Mounjaro Price Increase in the UK: What It Means & Why Patients Are Switching to Wegovy

Already a SynovaMed patient? There will be no immediate price change on your next order, and you don’t need to contact us. We will keep you updated about any adjustments to your plan and support you in choosing the best, most affordable option.

Medically reviewed by: Dr. Earim Chaudry (MBBS)

Written by: Roj Helin Parlakyildiz (MPharm)

Updated: 16th December 2025

Presented by SynovaMed – Your Trusted UK Pharmacy

If you are currently prescribed Mounjaro (tirzepatide) or are researching UK weight loss injections, you may have heard some frustrating news regarding treatment costs. Eli Lilly, the manufacturer of Mounjaro, has significantly increased the wholesale price of the medication across the UK.

This change affects all healthcare providers and pharmacies, raising valid concerns about long-term affordability and access to care. While Mounjaro remains a clinically proven and highly effective weight loss treatment, these rising costs are prompting many patients to explore alternatives—particularly Wegovy (semaglutide), which has become a much more cost-effective choice.

Here is an expert look at the Mounjaro price increase UK impact, what it means for your treatment, and how we are handling it at SynovaMed.

What’s Driving the Mounjaro Price Hike?

The cost to buy Mounjaro UK has increased nationwide. It is important to be candid about where this is coming from: this decision comes directly from the manufacturer, Eli Lilly, not your pharmacy or clinic.

According to Eli Lilly, the UK list price for Mounjaro was increased from 1st September 2025 to align it more closely with pricing in other developed countries. When Mounjaro initially launched in the UK, the price was set intentionally lower to help patients access the treatment quickly. However, citing newer evidence and global market shifts, the manufacturer has adjusted the pricing to match international standards.

Because clinics and pharmacies buy these medicines from wholesalers, a jump in the list price directly impacts the cost passed on to patients.

Key takeaways:

• Mounjaro remains a safe, effective, and trusted treatment. If you are happy and able to continue your current medication, it is absolutely fine to do so.
• This price increase applies to every single UK provider, whether you use a local pharmacy, a private clinic, or a digital healthcare provider like SynovaMed.

What This Means for SynovaMed Patients

At SynovaMed, we understand how disruptive sudden price increases can be to your weight management journey. Our goal is to keep your care as smooth, accessible, and affordable as possible, which is why we have absorbed as much of the manufacturer’s price hike as we can.

New to SynovaMed

If you are just starting your journey with us, you will see the updated Mounjaro prices at checkout. However, if you are strictly comparing options based on cost, Wegovy is currently the most cost-effective GLP-1 treatment at SynovaMed.

Existing SynovaMed Patients

If you are already a patient with us, your plan will transition to our dedicated existing-customer Mounjaro rates. These are lower than the prices new patients will pay because we have chosen to absorb more of the recent price rise on your behalf to protect your progress.

Your Treatment Options

Navigating a price increase can feel overwhelming, but you have choices. At SynovaMed, we are here to support whichever path you take:

1. Stay on Mounjaro at Your Current Dose: You can continue your tirzepatide treatment without interruption. Your monthly price will simply reflect the updated existing-customer rate.
2. Switch to Wegovy: If you are clinically suitable and looking to manage costs, transitioning to Wegovy is a smart move. Wegovy is currently the most cost-effective option at SynovaMed, with longer 3- and 6-month plans available to reduce your monthly costs even further. (Note: Where eligible, a £50 switch credit may be applied for existing customers moving from Mounjaro to Wegovy).
3. Consider a Mounjaro Dose Reduction: If you prefer to stay on Mounjaro but want to mitigate the cost, you can discuss stepping down a dose with your SynovaMed prescriber. For some, this keeps the monthly price closer to their original budget. Any changes must be prescriber-guided.

Mounjaro vs Wegovy: Why Wegovy is Now the Go-To Alternative

We know that a sudden cost increase can make continued treatment difficult. That is why many of our patients are opting to switch from Mounjaro to Wegovy. Beyond just being more affordable, Wegovy (semaglutide) brings several compelling advantages to the table:

• Comparable Weight Loss Results: The expected Wegovy 7.2mg dose demonstrated an average weight loss of 20.7% in the STEP-UP trial. Notably, one in three participants lost 25% or more of their body weight, narrowing the performance gap with higher-dose Mounjaro.
• Proven Cardiovascular Benefits: Wegovy is currently the only GLP-1 medication licensed in the UK to reduce the risk of major cardiac events (like heart attacks and strokes) in people with obesity and established heart disease, based on the SELECT CVOT trial. While recent data suggests Mounjaro offers similar protection, it is not yet officially approved for this in the UK.
• Long-Term Affordability: Following Eli Lilly’s price hike, Wegovy has become the significantly more accessible option. At SynovaMed, our affordable, longer-term plans are designed to support consistent treatment and better long-term outcomes without breaking the bank.

How Switching Works Safely at SynovaMed

Switching medications is not about starting over; it is about continuing your progress safely. Through our prescriber-guided switching pathway, we make moving from Mounjaro to Wegovy seamless.

We don’t just apply a standard protocol. We tailor your starting dose based on clinical data, how long you’ve been on treatment, your last dose, and your history of side effects.

Here is what you can expect:

• If you tolerated Mounjaro well: We may suggest starting on a slightly higher dose of Wegovy to maintain your momentum and avoid unnecessary plateaus or regressions.
• If you experienced side effects: (such as nausea or bloating on Mounjaro), we will likely recommend a more gradual starting dose for Wegovy to give your body time to adjust comfortably and reduce the risk of symptoms returning.
• Step-Up Schedule: Just like with Mounjaro, you will increase your Wegovy dose every 4 weeks until you reach your optimal maintenance dose—the one that consistently manages your appetite.

A Note on Off-Label Prescribing: Standard guidance usually dictates starting a new medication at the lowest possible dose. However, for patients switching from Mounjaro, starting at a slightly higher Wegovy dose is considered "off-label." At SynovaMed, our clinicians use the best available evidence and your specific treatment history to ensure this approach is clinically appropriate and safe for you.

Ready to Explore Your Options?

If the Mounjaro price increase has you concerned about the future of your weight loss journey, you don't have to navigate it alone. Our clinical team at SynovaMed is ready to help you compare treatments and seamlessly guide you through your next steps so you can continue your progress without interruption.